International Stem Cell Corporation (ISCO)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Anti-Aging Market (LSC)	598.00K	795.00K	923.00K	1.05M	1.24M
Anti-Aging Market (LSC) Growth	-24.78%	-13.87%	-12.01%	-15.40%	-19.17%
Biomedical Market (LCT)	8.50M	8.29M	6.87M	7.13M	5.94M
Biomedical Market (LCT) Growth	2.56%	20.74%	-3.72%	20.13%	6.11%
Total	9.10M	9.09M	7.79M	8.18M	7.18M
Total Growth	0.17%	16.64%	-4.78%	13.99%	0.67%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States (US)	7.84M	7.73M	6.55M	7.02M	5.92M
United States (US) Growth	1.44%	18.01%	-6.67%	18.57%	-
Asia	719.00K	890.00K	726.00K	690.00K	806.00K
Asia Growth	-19.21%	22.59%	5.22%	-14.39%	49.81%
Europe	448.00K	407.00K	395.00K	393.00K	345.00K
Europe Growth	10.07%	3.04%	0.51%	13.91%	18.97%
All Other Regions	95.00K	61.00K	120.00K	81.00K	108.00K
All Other Regions Growth	55.74%	-49.17%	48.15%	-25.00%	369.57%
Total	9.10M	9.09M	7.79M	8.18M	7.18M
Total Growth	0.17%	16.64%	-4.78%	13.99%	0.67%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 7, 2026

Data Sources Report a data error